Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

ClinicalTrials.gov ID: NCT00002220

Public ClinicalTrials.gov record NCT00002220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 3:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-Center, Open-Label Study of the Effect of Indinavir, Efavirenz, and Adefovir Dipivoxil Combination Therapy in Patients Who Have Failed Nelfinavir

Study identification

NCT ID
NCT00002220
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
120 participants

Conditions and interventions

Conditions

Interventions

  • Indinavir sulfate Drug
  • Efavirenz Drug
  • Levocarnitine Drug
  • Adefovir dipivoxil Drug

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
LAC / USC Med Ctr / Infectious Diseases Los Angeles California 90033
Yale Univ / AIDS Clinical Trials Unit New Haven Connecticut 06510
Med Ctr of Delaware Wilmington Delaware 19899
Hawaii AIDS Clinical Trial Unit Honolulu Hawaii 96816
Rush Presbyterian Saint Lukes Med Ctr Chicago Illinois 606123832
Johns Hopkins Hosp Baltimore Maryland 212876220
Massachusetts Gen Hosp Boston Massachusetts 02114
Columbia Presbyterian Hosp New York New York 10032
AIDS TMT Unit / Univ Hosp Stony Brook New York 117948153
Vanderbilt Clinic Nashville Tennessee 37212
Oaklawn Physicians Group Dallas Texas 75219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →